SFTPD and chronic obstructive pulmonary disease: COPD subjects who had serum SP-D concentrations in the upper 5th percentile of non-smokers had (i) increased risk of exacerbations over the following 12 months [25], and (ii) increased serum SP-D concentrations during exacerbation of COPD compared with stable COPD [34,35].